Actavis PLC (NYSE:ACT)

301.32
Delayed Data
As of Mar 26
 +0.69 / +0.23%
Today’s Change
184.71
Today|||52-Week Range
317.72
+17.06%
Year-to-Date

Today’s Trading

Previous close300.63
Today’s open298.00
Day’s range-- - --
Volume3,274,209
Average volume (3 months)3,190,893
Market cap$122.0B
Dividend yield--
Data as of 03/26/2015

Growth & Valuation

Earnings growth (last year)-40.80%
Earnings growth (this year)+23.69%
Earnings growth (next 5 years)+15.00%
Revenue growth (last year)+50.53%
P/E ratioNM
Price/Sales4.33
Price/Book2.83

Competitors

 Today’s
change
Today’s
% change
GSKGlaxoSmithKline-0.69-1.46%
SNYSanofi-1.50-2.98%
BMYBristol-Myers Squibb+0.30+0.46%
NVONovo Nordisk+3.44+6.90%
Data as of 03/26/2015

Financials

Next reporting dateApril 29, 2015
EPS forecast (this quarter)$3.97
Annual revenue (last year)$13.1B
Annual profit (last year)-$1.6B
Net profit margin-12.48%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Generic
President, Chief Executive Officer &
Director
Brenton L. Saunders
Chief Operating Officer
Robert A. Stewart
Corporate headquarters
Dublin, Dublin

Forecasts

To view my watchlist

Not a member yet?

Sign up now for a free account